Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
99 100 Next >
$3 Billion Suicidal Depression Market May Soon be Accessible via FDA Fast Track Designation for Effective NRX 100 Drug Therapy: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Tickers NRXP
Exposures Product Safety
This Stock Has Tumbled 50% In One Year, Gets A Price Target Cut Today – But Retail Believes $400-450 Is A Good Entry Point
Via Stocktwits
Tickers AVUS DWSH NVS REGN
Exposures Product Safety
FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply
Via Benzinga
Tickers MRNA NVAX PFE
Exposures COVID-19 Product Safety
FDA Fast Track Designation for $3 Billion Suicidal Depression Market May Soon be Accessible for Effective NRX 100 Drug Therapy: NRx Pharmaceuticals
Via PRLog
Exposures Product Safety
MindMed (MNMD) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings Initial Public Offering
Tickers MNMD
Exposures Financial Product Safety Securities Market
IO Biotech Stock Slumps After Trial Of Cancer Therapy Plus Keytruda Misses Study Goal: Retail Sees Shares Rise 10x
Via Stocktwits
Tickers IOBT MRK
Exposures Product Safety
IO Biotech's Combo Therapy For Skin Cancer Falls Just Short, Eyes FDA Talks Later This Year
Via Benzinga
Tickers IOBT MRK
Exposures Product Safety
PharmaTher Announces FDA Approval of Ketamine (KETARx(TM))
Via Newsfile
Tickers CSE:PHRM PHRRF
Exposures Product Safety
AORT Q2 Deep Dive: Product Momentum and Pipeline Advances Drive Upgraded Guidance
Via StockStory
Tickers AORT
Exposures Product Safety
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Signs CDMO Agreement for Oral Lucid-MS in Phase 2 MS Trial
Via Investor Brand Network
Tickers CSE:QNTM QNTM
Exposures Product Safety
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Steps Aside Temporarily to Run for Irish Presidency
Via Investor Brand Network
Topics Intellectual Property
Tickers NTRB
Exposures Intellectual Property Product Safety
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi &amp; Korsinsky for More Information - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Rocket Pharmaceuticals, Inc. (RCKT) Shareholders
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Replimune Group, Inc. Sued for Securities Law Violations - Contact Levi &amp; Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Reports Q2 2025 Results and Business Highlights
Via Investor Brand Network
Tickers CLDI
Exposures Product Safety
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Replimune Group, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Rocket Pharmaceuticals, Inc. (RCKT) Shareholders
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Fast Track Designation for NRX-100 in Treating Suicidal Ideation in Depression
Via Investor Brand Network
Tickers NRXP
Exposures Product Safety
Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction
Via Benzinga
Tickers CABA MRNA NGNE NVAX QURE SRPT
Exposures Product Safety
Agenus Posts 48% Q2 Revenue Miss
Via The Motley Fool
Tickers AGEN
Exposures Product Safety
MindMed Reports Strong Q2 2025 Results
Via The Motley Fool
Tickers MNMD
Exposures Product Safety
Trump Ally Laura Loomer Calls Vinay Prasad A ‘Marxist Trojan Horse’ After FDA Rehiring, Slams NASA For Dropping Isaacman
Via Stocktwits
Topics Death Government
Tickers SRPT
Exposures COVID-19 Death Political
Shark Tank Star Recalls How A Nearly Bankrupt Trump Sold NYC's Plaza Hotel Without Even Pitching It — 'Best Salesman I've Ever Met'
Via Benzinga
Topics Bankruptcy Government Product Recall
Exposures Financial Legal Political
Entera Bio Beats Q2 EPS Estimates
Via The Motley Fool
Topics Intellectual Property
Tickers ENTX
Exposures Intellectual Property Product Safety
Why LifeStance Health Group (LFST) Stock Is Up Today
Via StockStory
Topics Earnings Initial Public Offering Lawsuit
Tickers HUM LFST
Exposures Financial Legal Product Safety
Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79%
Via Benzinga
Tickers ABBV GMAB JNJ NVS
Exposures Product Safety
Earnings Season Highlights: Gilead Sciences and Expedia Group Post Strong Results
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Tickers C EXPE GILD GOOGL GS JPM
Exposures Artificial Intelligence Economy Financial
Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue
Via Benzinga
Topics Death
Tickers BSX
Exposures Death Product Safety
Why Is Artivion (AORT) Stock Rocketing Higher Today
Via StockStory
Tickers AORT
Exposures Product Safety
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.